Term
|
Definition
| High potency typical antipsychotic |
|
|
Term
|
Definition
| High potency typical antipsychotic |
|
|
Term
|
Definition
| High potency typical antipsychotic |
|
|
Term
|
Definition
| High potency typical antipsychotic |
|
|
Term
|
Definition
| High potency typical antipsychotic |
|
|
Term
|
Definition
| Mid potency typical antipsychotic |
|
|
Term
|
Definition
| Mid potency typical antipsychotic |
|
|
Term
|
Definition
| Mid potency typical antipsychotic |
|
|
Term
|
Definition
| Low potency typical antipsychotic |
|
|
Term
|
Definition
| Low potency typical antipsychotic |
|
|
Term
|
Definition
| Low potency typical antipsychotic |
|
|
Term
|
Definition
Atypical antipsychotic
Gold standard
Wide antagonism |
|
|
Term
|
Definition
Atypical antipsychotic
Most "typical" of atypicals (EPS possible)
Depot formulation like haloperidol and fluphenazine |
|
|
Term
|
Definition
Atypical antipsychotic
Sedating
Orthostatic hypotension |
|
|
Term
|
Definition
Atypical antipsychotic
Second-most effective after clozapine
Highest metabolic symptoms |
|
|
Term
|
Definition
Atypical antipsychotic
Prolonged QT interval |
|
|
Term
|
Definition
Atypical antipsychotic
Antagonist at 5HT2A, partial agonist at D2 and 5HT1A |
|
|
Term
|
Definition
Atypical antipsychotic
Metabolite of ripseridone |
|
|
Term
|
Definition
Atypical antipsychotic
Lowest weight gain?
Possible prolonged QT interval |
|
|
Term
|
Definition
Atypical antipsychotic
Novel mechanism of action |
|
|
Term
|
Definition
Tricyclic, 3rd
Used for pain, headache, insomnia |
|
|
Term
|
Definition
Tricyclic, 3rd
Highly serotonergic
Indicated for OCD |
|
|
Term
|
Definition
Tricyclic, 3rd
Used for pain, insomnia, anxiety |
|
|
Term
|
Definition
|
|
Term
|
Definition
Tricyclic, 3rd
Used for panic, enuresis |
|
|
Term
|
Definition
Tricyclic, 2nd
Demethylated imipramine
Least acetylcholinergic |
|
|
Term
|
Definition
Tricyclic, 2nd
Demethylated amitriptyline
Least orthostasis |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
MAOI
Patch form
Lower dietary restrictions at lower doses |
|
|
Term
|
Definition
SSRI
Longest t1/2
Efficacy in bulimia |
|
|
Term
|
Definition
SSRI
More sedating than fluoxetine or sertraline |
|
|
Term
|
Definition
SSRI
Less sedating than paroxetine |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
SNRI
Superior efficacy for depression among all antidepressants |
|
|
Term
|
Definition
SNRI
Nausea common
Used for diabetic neuropathy |
|
|
Term
|
Definition
SNRI
Metabolite of venlafaxine |
|
|
Term
|
Definition
NaSSA
Also blocks 5HT2A, 5HT3, 5HT2C, and H1 receptors |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Noradrenergic and dopamine reuptake inhibitor |
|
|
